
Rosen Investor Counsel’s Encouragement: Neumora Therapeutics’ Bright Future with Trusted Guidance
Important Information for Neumora Therapeutics, Inc. (NMRA) Investors: Deadline Reminder for Securities Class Action If you’re one of the many investors who purchased Neumora Therapeutics, Inc. (NMRA) common stock during the company’s September 2023 initial public offering (IPO), you might want to pay attention to this announcement. The Rosen Law Firm, a leading investor rights…